Showing results (1-10 of 328) with videos related to
Sort By:
Pageof 33
Neurobiology of Disease|January 30, 2008
Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET studyRobert Y Moore, Alan L Whone, David J BrooksBrain Research|August 14, 2003
Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET studyRobert Y Moore, Alan L Whone, Stephen McGowan, et al.Annals of Neurology|January 31, 2003
Plasticity of the nigropallidal pathway in Parkinson's diseaseAlan L Whone, Robert Y Moore, Paola P Piccini, et al.Frontiers in Psychology|March 2, 2013
Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson's diseaseAndrew D Lawrence, David J Brooks, Alan L WhoneNeuropsychologia|September 24, 2004
Cognitive and motor effects of dopaminergic medication withdrawal in Parkinson's diseaseLiory Fern-Pollak, Alan L Whone, David J Brooks, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter studyAlan L Whone, Dale L Bailey, Philippe Remy, et al.Neuroimage|March 15, 2011
Progression of monoaminergic dysfunction in Parkinson's disease: a longitudinal 18F-dopa PET studyNicola Pavese, Maria Rivero-Bosch, Stephanie J Lewis, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Opioid binding in DYT1 primary torsion dystonia: an 11C-diprenorphine PET studyAlan L Whone, Sarah Von Spiczak, Mark Edwards, et al.Brain : a Journal of Neurology|February 25, 2005
The role of opioids in restless legs syndrome: an [11C]diprenorphine PET studySarah von Spiczak, Alan L Whone, Alexander Hammers, et al.JMIR Human Factors|July 7, 2022
Acceptability of an In-home Multimodal Sensor Platform for Parkinson Disease: Nonrandomized Qualitative StudyCatherine Morgan, Emma L Tonkin, Ian Craddock, et al.Pageof 33